María Reyes Abad-Sazatornil

5PUBLICATIONS
15CO-AUTHORS
Cardiology (incl. cardiovascular diseases)Pharmacology and pharmaceutical sciences not elsewhere classifiedPharmacogenomicsIntensive careCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 14, 2026
LDL-C target attainment and treatment costs in high-risk and very-high-risk patients with or without bempedoic acid: A Spanish cohort simulation.

|Jan 30, 2025
Value contribution of leniolisib in the Treatment of Activated PI3Kδ syndrome (APDS) in Spain using Multi-Criteria Decision Analysis (MCDA).

María Reyes Abad, Carmen Alerany, Luis Ignacio González

|May 24, 2024
Determining value in the treatment of activated PI3Kδ syndrome in Spain: a multicriteria decision analysis from the perspective of key stakeholders.

María Reyes Abad, Carmen Alerany, Laia Alsina

|Apr 09, 2021
Impact of the subcutaneous formulations of trastuzumab and rituximab on efficiency and resource optimization in Spanish hospitals: H-Excelencia study.

María Reyes Abad-Sazatornil, Ainhoa Arenaza, Juan Bayo

|Jan 12, 2021
Analysis of first-line treatment in older patients with metastasic colorectal cancer.

Arantxa Magallón Martínez, Maria J Agustín Ferrández, Andrea Pinilla Rello

Pageof 1

Frequent Collaborators

2 joint publications

Alicia Gil

1 joint publications

Arantxa Magallón Martínez

1 joint publications

Maria J Agustín Ferrández

1 joint publications

Andrea Pinilla Rello